Health ❯ Healthcare ❯ Clinical Trials ❯ Drug Efficacy

Weight Loss Studies

GLP-1 Pills Accelerate into U.S. Care with Amazon Rollout and New Evidence on Use and Response

New retail access, early clinical signals, genetic findings point to a fast shift from injections to daily tablets.

FDA Clears Eli Lilly’s Foundayo Oral GLP-1 for Weight Loss, With U.S. Launch Set for April 6

Novo Nordisk Launches Wegovy Weight-Loss Drug in India